MeiraGTx's innovative gene therapies for ocular diseases & more are backed by strong clinical data and funding. Click here to find out why MGTX stock is a Buy.

The macromolecular organization of photosynthetic complexes within the thylakoids of higher plant chloroplasts has been a topic of significant debate. Using in situ cryo-electron tomography, this ...

Weiss Ratings reiterated their sell (e+) rating on shares of 4D Molecular Therapeutics (NASDAQ:FDMT – Free Report) in a ...

Shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) have been assigned a consensus recommendation of ...

The alpha-gal syndrome is thought to be triggered by bites from the lone star tick. Emerging evidence suggests other ...

A collaborative study led by Prof. Liu Guanghui from the Institute of Zoology of the Chinese Academy of Sciences and Dr. Wang ...

VAEs also introduce mathematical constraints that accommodate computational models called large neural networks. To continue with the example of large language models, these neural networks can be ...

Immunotherapy has emerged as one of the major options for cancer treatment in the past decade. With the successful application of immune checkpoint inhibitors and the introduction of immune regulatory ...

Researchers discuss a novel method to predict biological aging using a deep neural network based on pathways of ...

Department of Chemical Engineering, National Taiwan University of Science and Technology, Taipei 106, Taiwan Sustainable Electrochemical Energy Development Center (SEED Center), National Taiwan ...

EMERYVILLE, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...

Good morning, and welcome to the Molecular Partners Fourth Quarter and ... And as you know, in the radio field, we bring the vector, but we still need access to an isotope. And isotope supply ...